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The past few years have witnessed increasing interest in the
possibility that chronic asymptomatic infection with the
airborne agent Chlamydia pneumoniae might contribute to
atherogenesis and, possibly, to plaque instability and acute
coronary syndromes (1–4). C. pneumoniaeexist within coro-
nary plaques (5, 6). Also, some recent preliminary studies
show that treatment with macrolide antibiotics might
reduce recurrent coronary events in patients who have sus-
tained acute myocardial infarction (7, 8), and may limit
development of atherosclerosis in rabbits (9).
However, the molecular mechanisms by which C. pneu-
moniaemight contribute to atheroma formation and evo-
lution remain unclear. We have recently demonstrated
that chlamydial heat shock protein 60 (HSP 60), pro-
duced in large amounts during chronic chlamydial infec-
tions, colocalizes within plaque macrophages with
human HSP 60 (10). In addition, we have made the sur-
prising observation that either chlamydial or human HSP
60, normally intracellular proteins with protective func-
tion, can act as extracellular agonists and induce tumor
necrosis factor-a(TNF-a) and matrix metalloproteinase
(MMP-9) production by mouse macrophages (10).
C. pneumoniaecan infect human endothelial cells (ECs)
(11), where it induces the expression of adhesion mole-
cules like endothelial-leukocyte adhesion molecule-1 (E-
selectin), intercellular adhesion molecule-1 (ICAM-1),
and vascular cell adhesion molecule-1 (VCAM-1) (12). C.
pneumoniae also infects human monocyte–derived
macrophages, stimulating the production of proinflam-
matory cytokines such as TNF-aand interleukin-6 (IL-6)
(13). In addition, C. pneumoniae can infect human smooth
muscle cells (SMCs) (14), although the effects of infection
on this cell type have not been studied. In the view of the
high levels of expression of chlamydial HSP 60 during
chronic, persistent chlamydial infections (15, 16), our
recent findings raise the intriguing possibility that
chlamydial HSP 60, may activate human vascular cells
(ECs, SMCs) and infiltrating macrophages, and may
thereby mediate the inflammation that appears to pro-
mote atheroma formation and evolution. The induction
of adhesion molecules on infected endothelium might
aid trafficking of monocytes and lymphocytes in athero-
ma (17, 18). The induction of proinflammatory cytokines
such as TNF-aor IL-6 might promote plaque instability
and thrombosis (19, 20). Because human atheroma con-
tain both human and chlamydial HSP 60s (10, 21), and
HSP 60s from different species share a substantial
sequence similarity (22), chlamydial and human HSP 60s
might have similar functions on human vascular cells.
This study therefore tested the hypothesis that chlamy-
dial HSP 60 may activate human vascular cells and
macrophages and that human HSP 60 shares similar
actions. We examined the expression of adhesion molecules
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Both chlamydial and human heat shock protein 60s (HSP 60), which colocalize in human atheroma,
may contribute to inflammation during atherogenesis. We tested the hypothesis that chlamydial or
human HSP 60 activates human endothelial cells (ECs), smooth muscle cells (SMCs), and monocyte-
derived macrophages. We examined the expression of adhesion molecules such as endothelial-leuko-
cyte adhesion molecule-1 (E-selectin), intercellular adhesion molecule-1 (ICAM-1), and vascular cell
adhesion molecule-1 (VCAM-1), and the production of the proinflammatory cytokine interleukin-6 (IL-
6). We also tested whether either HSP 60 induces nuclear factor-kB (NF-kB), which contributes to the
gene expression of these molecules. Either chlamydial or human HSP 60 induced E-selectin, ICAM-1,
and VCAM-1 expression on ECs similar to levels induced by Escherichia coli lipopolysaccharide (LPS).
Each HSP 60 also significantly induced IL-6 production by ECs, SMCs, and macrophages to an extent
similar to that induced by E. coli LPS, as assessed by enzyme-linked immunosorbent assay (ELISA). In
ECs, either HSP 60 triggered activation of NF-kB complexes containing p65 and p50 Rel proteins. Heat
treatment abolished all these effects, but did not alter the ability of E. coliLPS to induce these functions.
Chlamydial and human HSP 60s therefore activate human vascular cell functions relevant to athero-
genesis and lesional complications. These findings help to elucidate the mechanisms by which a chron-
ic asymptomatic chlamydial infection might contribute to the pathophysiology of atheroma. 
J. Clin. Invest. 103:571–577 (1999).on ECs (E-selectin, ICAM-1, and VCAM-1) and on SMCs
(ICAM-1 and VCAM-1) and the production of a proin-
flammatory cytokine (IL-6) by ECs, SMCs, and monocyte-
derived macrophages. Because E-selectin, ICAM-1, VCAM-
1, and IL-6 gene expression involves activation of nuclear
factor-kB (NF-kB) (23), we also tested the hypothesis that
HSP 60s trigger NF-kB activation.
Methods
Reagents. The recombinant Chlamydia trachomatisHSP 60 fusion
protein expression plasmid was the gift of R. Stephens (Uni-
versity of California–San Francisco, San Francisco, California,
USA) (24). Production of chlamydial HSP 60, purification, and
site-specific proteolysis with thrombin were performed as
described elsewhere (25) using a RediPack GST Purification
Module (Pharmacia Biotech, Piscataway, New Jersey, USA).
Recombinant human HSP 60 was purchased from StressGen
Biotechnologies Corp. (Victoria, British Columbia, Canada). E.
colilipopolysaccharide (LPS) was purchased from Sigma Chem-
ical Co. (St. Louis, Missouri, USA). Formalin-inactivated C.
pneumoniaeelementary bodies were obtained from Washington
Research Foundation (Seattle, Washington, USA).
Cell isolation and culture. Human vascular ECs from human
umbilical cord and SMCs from saphenous veins were isolated and
cultured as described (26, 27). Vascular SMCs and ECs were cul-
tured in DMEM and M199 medium (BioWhittaker, Walkersville,
Maryland, USA), respectively. Both culture media contained 10%
FCS (HyClone Laboratories, Logan, Utah, USA); endothelial cell
growth supplement and heparin were added to ECs culture medi-
um (28). Vascular SMCs were cultured 48 h before the experiment
in insulin/transferrin medium lacking fetal calf serum (29).
Monocytes were isolated from freshly prepared human
peripheral blood mononuclear cells obtained from leukopacs
of healthy donors (provided by S.K. Clinton, Ohio State Uni-
versity, Columbus, Ohio, USA) by density gradient centrifuga-
tion (30), and by adherence to plastic culture flasks (2 h at
37°C). Monocytes were harvested by incubation with PBS-
EDTA for 10 min at 37°C and plated at a density of 5 ´ 105
cells/cm2in RPMI-1640 medium (BioWhittaker) containing 5%
human serum (Sigma Chemical Co.). Cells were cultured for
7–10 days, serum was added every 2 days, and medium was
changed every 4 days. For specific experiments, macrophages
were precultured 18 h in RPMI-1640 lacking serum.
Experimental conditions and preparation of conditioned medium. Cells
were incubated with recombinant chlamydial HSP 60, human
HSP 60, inactivated C. pneumoniae, E. coli LPS, or with medium
alone as a negative control. In the same experiments, before incu-
bation, a portion of each reagent was heat-treated by boiling for
20 min. Concentrations used and incubation periods are indicat-
ed in individual experiments. Concentrations of inactivated C.
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Figure 1
Chlamydial and human HSP 60s induce E-selectin production by endothelial cells. (top) ECs were incubated with medium only (unstimulated con-
trol), or with chlamydial HSP 60 (5 mg/ml), human HSP 60 (5 mg/ml), E. coli LPS (1 mg/ml), or inactivated C. pneumoniae (107 U/ml), for 6 h. Cells
were harvested by treatment with trypsin-EDTA and then stained with antibody against E-selectin (solid histograms) or with mouse IgGs (as isotype
control; open histograms). Chlamydial HSP 60 and human HSP 60 had a similar effect on E-selectin production as E. coli LPS. Inactivated C. pneumoni-
ae did not elicit E-selectin expression by ECs. (bottom) Before incubation, reagents were heat-treated by boiling for 20 min. Heat treatment abolished
the effect on E-selectin by chlamydial HSP 60 and human HSP 60, but did not modify the effect of thermostable E. coli LPS. Three independent exper-
iments showed similar results. EC, endothelial cells; HSP, heat shock protein; LPS, lipopolysaccharide.
Table 1
Percentages of endothelial cells positively stained for E-selectin,
ICAM-1, and VCAM-1
E-selectin ICAM-1 VCAM-1
Unstimulated control 3% 16% 2%
LPS 88% 93% 29%
LPS (heat-treated) 89% 88% 32%
Chlamydial HSP 60 76% 73% 15%
Chlamydial HSP 60 (heat-treated) 16% 18% 2%
Human HSP 60 74% 71% 15%
Human HSP 60 (heat-treated) 9% 18% 2%
C. pneumoniae 9% 19% 2%
C. pneumoniae (heat-treated) 6% 15% 3%
ICAM-1, intercellular adhesion molecule-1; VCAM-1, vascular cell adhesion
molecule-1; LPS, lipopolysaccharide; HSP, heat shock protein.pneumoniaeare expressed as U/ml, which correspond to the num-
ber of microorganisms per ml of culture medium. Conditioned
medium was collected at different time points and frozen for fur-
ther analysis. Each experiment was repeated at least three times.
Flow cytometry. Human SMCs and ECs were first harvested by
incubation with HBSS containing trypsin-EDTA (Sigma
Chemical Co.). Cells were then incubated (30 min at 4°C) with
the specific primary antibody: antibodies against human E-
selectin (H18/7) (31), ICAM-1 (Hu5/3) (32), and VCAM-1(E1/6)
(33) were a generous gift of M. Gimbrone (Brigham and
Women’s Hospital, Boston, Massachusetts, USA); control
mouse IgGs were purchased from PharMingen (San Diego, Cal-
ifornia, USA). Cells were thereafter incubated (30 min at 4°C)
with FITC-conjugated secondary antibodies against mouse
IgG1 (Southern Biotechnology Associates, Birmingham,
Alabama, USA) and fixed in 1% paraformaldehyde. FACS analy-
sis was performed with a FACScan flow cytometer, and data
were analyzed using CELLQUEST software (Becton Dickinson
and Co., Franklin Lanes, New Jersey, USA). Data are represent-
ed as percentages of positively stained cells.
Cytokine assay. IL-6 levels in culture supernatants were measured
by ELISA using paired antibodies purchased from Endogen Inc.
(Woburn, Massachusetts, USA). Samples were assayed in triplicate.
Antibody binding was detected by adding P-nitrophenyl phos-
phate (1 mg/ml; Sigma Chemical Co.). Absorbance was measured
in a Dynatech plate reader at 410 l. The amount of cytokine
detected was calculated from a standard curve prepared from the
recombinant cytokine purchased from Endogen Inc.
Data are expressed as mean ± SEM. Differences between
experimental conditions were assessed by ANOVA with Bon-
ferroni correction. P ≤ 0.05 was considered significant.
Isolation of nuclear proteins and electromobility shift assay. Human
umbilical vein endothelial cells (HUVECs) grown to confluency
in 10-cm2 dishes were treated with chlamydial or human HSP
60 (2 mg/ml) or with LPS (1 mg/ml) for the indicated time peri-
ods. Nuclear proteins were extracted by the method of Dignam
(34) with modifications (35). Double-stranded oligonucleotides
that span the NF-kB–binding site of the human IL-6 promoter
(GGGATTTTCCC), purchased from Integrated DNA Tech-
nologies (Coralville, Iowa, USA), were annealed and labeled with
[32 P]ATP using T4 polynucleotide kinase. For electromobility
shift assay (EMSA), 5 mg of nuclear extract was combined in 20
ml buffer containing 10 mM Tris-HCl (pH 7.5), 50 mM NaCl, 1
mM EDTA, 5% glycerol, 1 mg poly (dI/dC), and 30,000-cpm
labeled probe (0.1–0.5 ng). The mixtures were incubated 30 min
at room temperature. For competition reactions, 50 ng of unla-
beled probe, consensus or mutant NF-kB oligomer (Santa Cruz
Biotechnology Inc., Santa Cruz, California, USA) were added 15
min before addition of labeled probe. Supershifts were per-
formed by adding 1 mg of polyclonal rabbit anti-Rel antibodies
or isotype-matched nonimmune IgG (Santa Cruz Biotechnolo-
gy Inc.) to reactions 20 min before addition of labeled probe.
Protein–DNA complexes were resolved on 5% polyacrylamide
gels run in 0.5´ Tris-borate buffer at 200 V for 2 h. Gels were
dried and exposed to autoradiography film for 16–24 h.
Results
Chlamydial and human HSP 60s induce E-selectin, ICAM-1, and
VCAM-1 expression on endothelial cells. Expression of adhe-
sion molecules on endothelium and/or smooth muscle
cells regulates the leukocyte trafficking within the vascu-
lar wall, likely contributing to atherogenesis (17, 18). We
therefore tested whether chlamydial or human HSP 60
can induce the expression of E-selectin on ECs, and of
ICAM-1 and VCAM-1 on ECs and SMCs. After six hours,
either chlamydial or human HSP 60 induced E-selectin
on ECs to an extent similar to that induced by E. coliLPS;
nonstimulated cells expressed very low levels of E-selectin
(Fig. 1, top; Table 1). After 24 hours, either chlamydial or
human HSP 60 induced ICAM-1 on ECs to an extent sim-
ilar to that induced by E. coli LPS; nonstimulated cells
expressed low levels of ICAM-1 (Fig. 2, top; Table 1).
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Figure 2
Chlamydial and human HSP 60s induce ICAM-1 production by endothelial cells. (top) ECs were incubated with medium only (unstimulated control),
or with chlamydial HSP 60 (5 mg/ml), human HSP 60 (5 mg/ml), E. coli LPS (1 mg/ml), or inactivated C. pneumoniae (107 mg/ml), for 24 h. Cells were
harvested by treatment with trypsin-EDTA and stained with antibody against ICAM-1 (solid histograms) or with mouse IgGs (as isotype control; open
histograms). Chlamydial HSP 60 and human HSP 60 had a similar effect on ICAM-1 production as E. coli LPS. Inactivated C. pneumoniae did not elicit
ICAM-1 expression by ECs. (bottom) Before incubation, reagents were heat-treated by boiling for 20 min. Heat treatment abolished the effect on
ICAM-1 by chlamydial HSP 60 and human HSP 60, but did not modify the effect of thermostable E. coli LPS. Three independent experiments showed
similar results. ICAM-1, intercellular adhesion molecule-1.Chlamydial or human HSP 60 also induced VCAM-1 on
ECs, as did E. coliLPS, although the level of expression was
lower than for E-selectin and ICAM-1 (Table 1). In con-
trast, SMCs showed no increase over basal levels of either
ICAM-1 or VCAM-1 (data not shown).
Infection of ECs with live C. pneumoniae induces the
expression of E-selectin, ICAM-1, and VCAM-1 (12).
However, it is not clear whether this effect is mainly
due to membrane constituents, such as LPS or the
major outer membrane protein (MOMP), or to cyto-
plasmic constituents, such as the chlamydial HSP 60.
Under the conditions used in this study, cells exposed
to formalin-inactivated C. pneumoniae, which retain
antigenicity (10) but cannot enter host cells, did not
show increased expression of E-selectin, ICAM-1, or
VCAM-1 (Figs. 1 and 2, top; Table 1). This observation
suggests that a cytoplasmic component, such as the
chlamydial HSP 60, and not a membrane constituent,
may be responsible for the observed effects on ECs
after infection with live C. pneumoniae.
Both the chlamydial and human HSP 60s used in this
study were prepared by expression in E. coli, therefore
contamination with E. coli LPS might account for the
observed effect of HSP 60s. To exclude this possibility,
we heat-treated the HSP 60s (both chlamydial and
human) and the control E. coli endotoxin. Bacterial
lipopolysaccharides exhibit thermostability, while most
proteins are thermolabile. Heat treatment of either
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Figure 3
Chlamydial and human HSP 60s induce IL-6
production by endothelial cells. (top) ECs were
incubated with medium only (unstimulated
control), or with chlamydial HSP 60 (5 mg/ml),
human HSP 60 (5 mg/ml), E. coli LPS (1 mg/ml),
or inactivated C. pneumoniae (107 U/ml), for 24
h. Samples were collected and analyzed for IL-
6 by ELISA. Chlamydial HSP 60 and human
HSP 60, as well as E. coli LPS, significantly
increased IL-6 production over control levels.
Inactivated C. pneumoniae did not elicit IL-6
expression by ECs. (bottom) Before incubation,
reagents were heat-treated by boiling for 20
min. Heat treatment abolished the effect on IL-
6 by chlamydial HSP 60 and human HSP 60,
but did not modify the effect of thermostable E.
coli LPS. Results shown represent the mean ±
SEM of three independent experiments. Statis-
tically significant vs. control (P ≤ 0.01, two-
sided). IL-6, interleukin-6.
Figure 4
Chlamydial and human HSP 60s induce IL-6
production by smooth muscle cells. (top)
SMCs were incubated without serum for 48 h
and then with medium only (unstimulated
control), or with chlamydial HSP 60 (5
mg/ml), human HSP 60 (5 mg/ml), E. coli LPS
(1 mg/ml), or inactivated C. pneumoniae (107
U/ml), for 24 h. Samples were collected and
analyzed for IL-6 by ELISA. Chlamydial HSP 60
and human HSP 60 significantly increased IL-
6 production over control levels. Neither E. coli
LPS nor inactivated C. pneumoniae did elicit IL-
6 expression by SMCs. (bottom) Before incu-
bation, reagents were heat-treated by boiling
for 20 min. Heat treatment abolished the
effect on IL-6 by both chlamydial HSP 60 and
human HSP 60. Results shown represent the
mean ± SEM of three independent experi-
ments. Statistically significant vs. control (P ≤
0.05, two-sided). SMCs, smooth muscle cells.
Figure 5
Chlamydial and human HSP 60s induce IL-6
production by monocyte-derived macrophages.
(top) Macrophages were incubated with medi-
um only (unstimulated control), or with
chlamydial HSP 60 (5 mg/ml), human HSP 60
(5 mg/ml), E. coli LPS (1 mg/ml), or inactivated
C. pneumoniae (107 U/ml), for 24 h. Samples
were collected and analyzed for IL-6 by ELISA.
Chlamydial HSP 60 and human HSP 60, as well
as E. coli LPS and inactivated C. pneumoniae, sig-
nificantly increased IL-6 production over con-
trol levels. (bottom) Before incubation, reagents
were heat-treated by boiling for 20 min. Heat
treatment abolished the effect on IL-6 by
chlamydial HSP 60, human HSP 60, and inac-
tivated C. pneumoniae, but did not modify the
effect of thermostable E. coli LPS. Results shown
represent the mean ± SEM of three independent
experiments. Statistically significant vs. control
(P ≤ 0.01, two-sided).chlamydial or human HSP 60 abrogated their ability to
induce E-selectin, ICAM-1, or VCAM-1, but did not alter
the effects of E. coli endotoxin (Figs. 1 and 2, bottom;
Table 1), thus indicating lack of appreciable contamina-
tion with LPS in the HSP 60 preparations.
Chlamydial and human HSP 60s induce IL-6 production by
ECs, SMCs , and macrophages. IL-6 is an important media-
tor of the acute phase response and can increase plasma
levels of fibrinogen, C-reactive protein (CRP), and serum
amyloid A protein (SAA) (36). Increased fibrinogen lev-
els might promote thrombosis on a preexisting athero-
ma, and levels of IL-6, CRP, and SAA correlate with
prognosis in patients with unstable angina (37, 38), and
with the risk of myocardial infarction in healthy subjects
(39). Infection of human monocytes with C. pneumoniae
induces the production of IL-6 (13). We therefore tested
whether chlamydial or human HSP 60 can induce IL-6
expression in ECs, SMCs, and macrophages. After 24
hours, chlamydial and human HSP 60s significantly
increased the expression of IL-6 by ECs (Fig. 3, top),
SMCs (Fig. 4, top), and macrophages (Fig. 5, top), as com-
pared with control levels. While inactivated C. pneumoni-
ae did not increase IL-6 expression by ECs and SMCs, it
elicited IL-6 production by monocyte-derived
macrophages (Figs. 3–5, top). This apparent discrepancy
might relate to the well-described phagocytic properties
of macrophages, a characteristic not prominent in either
ECs or SMCs. Interestingly, while E. coliLPS significant-
ly increased IL-6 expression in ECs and macrophages, it
did not affect IL-6 production by SMCs, further sup-
porting the lack of LPS contamination in the prepara-
tions of either HSP 60. Moreover, heat treatment of
either chlamydial or human HSP 60 abrogated their abil-
ity to induce IL-6 on ECs (Fig.3, bottom), SMCs (Fig. 4,
bottom), and macrophages (Fig. 5, bottom), but did not
alter the effect of E. coli endotoxin.
Chlamydial and human HSP 60s trigger NF-kB activation.
We have recently shown that either chlamydial or human
HSP 60 induce expression of TNF-a in mouse
macrophages (10), and we have extended these findings
to human macrophages (Kol, A., et al., unpublished obser-
vations). The present results show that either HSP 60 can
also induce E-selectin, ICAM-1, VCAM-1, and IL-6.
Because NF-kB transcriptional complexes contribute
importantly to the inducible expression of the genes
encoding E-selectin, ICAM-1, VCAM-1, IL-6, and TNF-a
(23), we sought evidence that HSP 60s trigger NF-kB acti-
vation. In particular, because IL-6 production was
induced by HSP 60s in all three cell types examined in
this study, we chose to detect NF-kB activation by a gel-
shift assay using an oligonucleotide probe that contains
the NF-kB–binding site of the IL-6 promoter. HSP 60s
did indeed activate NF-kB: a complex was evident by 30
minutes after stimulation and appeared maximal and
sustained from two to six hours (Fig. 6). The time course
of response to chlamydial or human HSP 60 resembled
that of LPS, a well-known activator of NF-kB (23). Heat
treatment of chlamydial or human HSP 60 nearly abol-
ished their ability to activate NF-kB, whereas the same
treatment did not affect the response to LPS, thus ren-
dering highly unlikely the possibility that LPS contami-
nation in our HSP 60 preparations accounted for the
observed effect on NF-kB activation (Fig. 7). Formation
of binding complexes from nuclear extracts of cells treat-
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Figure 7
Chlamydial and human HSP 60s induce NF-kB activation: effect of heat
treatment. Endothelial cells were incubated with medium only (unstimu-
lated control), or with chlamydial HSP 60 (2 mg/ml), human HSP 60 (2
mg/ml), or E. coliLPS (1 mg/ml) for 2 h. A portion of each reagent was heat-
treated before incubation by boiling for 20 min. Nuclear extracts were pre-
pared and subject to electromobility shift assay with an oligonucleotide
containing the NF-kB–binding site of the IL-6 promoter. Heat treatment
abolished the induction of NF-kB complex formation by chlamydial and
human HSP 60, but did not modify the effect of thermostable E. coli LPS. 
Figure 6
Chlamydial and human HSP 60s induce NF-kB activation in a time-
dependent fashion. Endothelial cells were incubated with medium only
(unstimulated control), or with chlamydial HSP 60 (2 mg/ml), human HSP
60 (2 mg/ml), or E. coli LPS (1 mg/ml) for 0.5, 2, and 6 h. Nuclear extracts
were prepared and subjected to electromobility shift assay with an
oligonucleotide containing the NF-kB–binding site of the IL-6 promoter.
NF-kB complex formation was evident by 30 min and appeared maximal
and sustained from 2 to 6 h. The time course of response to chlamydial
or human HSP 60 was similar to that of LPS. NF-kB, nuclear factor-kB.ed with human HSP 60 were prevented by competition
with unlabeled oligonucleotides containing the IL-6 or
consensus NF-kB site, but not by an oligomer containing
two point mutations in the IL-6 NF-kB site, verifying the
specificity of the induced complexes for binding of NF-
kB proteins (Fig. 8). Supershift analysis with a panel of
anti-Rel antibodies identified p65 (Rel A) and p50 as
components of human HSP–induced binding complex-
es, while antibodies to cRel, RelB, or nonimmune rabbit
IgG did not supershift any complex (Fig. 9).
Discussion
The molecular mechanisms by which a chronic asymp-
tomatic C. pneumoniae infection might contribute to
atherogenesis and lesional complications remain
obscure. This study demonstrated that chlamydial HSP
60, produced abundantly during chronic, persistent
chlamydial infections, activates human vascular cell and
macrophage functions related to atheroma formation
and lesional complications.
We aimed to identify possible molecular effectors of C.
pneumoniae contribution to atheroma. HSPs have been
implicated as antigens stimulating autoimmunity in
atherogenesis (40, 41). In addition, bacterial HSP 60, like
another microbial product such as LPS, may activate the
innate immune system (42). The findings of this study
suggest a new function for chlamydial and also human
HSP 60: the activation of intrinsic human vascular cells.
The HSPs markedly increased E-selectin and ICAM-1 lev-
els on endothelial cells and VCAM-1 to a much lesser
extent. In contrast, on SMCs HSPs augmented neither
ICAM-1 nor VCAM-1 expression. These distinct patterns
may reflect differences in culture conditions between
HUVECs and SMCs. However, IL-6 increased in all cell
types (HUVECs, SMCs, and monocyte-derived
macrophages). Therefore, the differences in the regula-
tion of adhesion molecule expression may also reflect
cell type–specific control mechanisms. In either case, the
expression of adhesion molecules by the endothelium
likely contributes to leukocyte recruitment during
atherogenesis, while the function of these molecules in
smooth muscle cells remains unclear (17, 18, 43).
HSPs (or chaperonins) are generally considered to act
intracellularly to preserve cellular protein stability in
response to conditions such as heat shock, nutrient depri-
vation, infections, and inflammatory reactions (44). Our
findings have particular interest, as they delineate a new
possible function for this class of proteins, particularly HSP
60. The ability of either chlamydial or human HSP 60 to
activate human vascular cells and to trigger NF-kB activa-
tion suggests a novel amplification loop in arterial inflam-
mation. Chronic, persistent C. pneumoniae infection could
provoke the expression of both chlamydial and human HSP
60s in the arterial wall. Both of these proteins could then
amplify the ongoing inflammatory process, through their
actions on human vascular cells described here.
Because HSPs usually localize within cells, they require
release into the extracellular space to activate vascular
cells. In this regard, it is well known that Chlamydiae,
during their life cycle, undergo both phases of chronic,
persistent, nonlytic infection, in which they remain
viable, but do not replicate, and phases of lytic infection
(15). During these lytic phases, the host cells release both
their own HSP 60, produced during the previous chron-
ic phase of infection, and also the human HSP 60, which
has been produced in the host cell in response to the
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Figure 8
Human HSP 60 induces NF-kB activation: specificity of DNA-binding
complexes. Endothelial cells were incubated with medium only
(unstimulated control), or with human HSP 60 (2 mg/ml) for 2 h.
Nuclear extracts were prepared and subject to electromobility shift
assay with an oligonucleotide containing the NF-kB–binding site of
the IL-6 promoter. Competition of DNA-binding activity in the pres-
ence of excess unlabeled competitor, consensus, or mutant NF-kB
oligonucleotides demonstrate specificity of HSP 60–induced NF-kB
DNA-binding complexes.
Figure 9
Human HSP 60 induces NF-kB activation: identification of p65 and p50 Rel
proteins as components of DNA-binding complexes. Endothelial cells were
incubated with medium only (unstimulated control), or with human HSP
60 (2 mg/ml) for 2 h. Rel proteins were identified by performing electromo-
bility shift assay on nuclear extracts, with an oligonucleotide containing the
NF-kB–binding site of the IL-6 promoter, in the presence of the indicated Rel
antisera or with nonimmune rabbit IgG. NF-kB and supershifted complex-
es are indicated on the left: p65 (Rel A) and p50 were identified as compo-
nents of human HSP–induced binding complexes, while antibodies to cRel,
RelB, or nonimmune rabbit IgG did not shift any binding complex. Probeonly
indicates electromobility shift assay performed without nuclear extract.infection and to previous noninfectious stimuli (44), and
which we and others have shown in human atheroma
(10, 21). In addition, several observations support the
occurrence of cell death within atheroma (45, 46), pro-
viding another pathway for release of HSPs from cells.
In conclusion, this study demonstrates that either
chlamydial or human HSP 60 activates human vascular
cell functions relevant to atherogenesis and lesional
complications. These findings contribute to our under-
standing of the molecular mechanisms by which a
chronic asymptomatic chlamydial infection might influ-
ence atherogenesis and trigger acute events.
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